Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIROUETTE study of ustekinumab in plaque psoriasis
2010-023901-36Phase 4Completed
- Sponsor
- Medical Faculty Magdeburg
- Start
- Jan 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ustekinumab in plaque psoriasis, sponsored by Medical Faculty Magdeburg. Primary endpoints: Antipsoriatic treatment response at week 24 with tissue and clinical assessment and Topoproteome analysis of skin tissue. Started Jan 2011; status: completed.
02
Drugs
ustekinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2010-023901-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023901-36.